Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for InMode Ltd. (INMD : NSDQ)

• Company Description    InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel. Number of Employees: 599

• Price / Volume Information    Yesterday's Closing Price: $15.36 Daily Weekly Monthly 20 Day Moving Average: 1,715,685 shares Shares Outstanding: 63.21 (millions) Market Capitalization: $970.89 (millions) Beta: 1.95 52 Week High: $19.85 52 Week Low: $13.14 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 5.49% 2.33% 12 Week -0.29% -13.57% Year To Date -8.02% -13.10%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL TAVOR BUILDING SHAAR YOKNEAM POB 533 - YOKNEAM,L3 2069200 ISR ph: 972-4909-7470 fax: - ir@inmodemd.com http://www.inmodemd.com

• General Corporate Information    Officers Moshe Mizrahy - Chief Executive Officer Michael Anghel - Chairman Yair Malca - Chief Financial Officer Bruce Mann - Director Nadav Kenneth - Director Peer Information InMode Ltd. (BJCT) InMode Ltd. (CADMQ) InMode Ltd. (APNO) InMode Ltd. (UPDC) InMode Ltd. (IMTIQ) InMode Ltd. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: M5425M103 SIC: 3845 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/07/25 Share - Related Items Shares Outstanding: 63.21 Most Recent Split Date: 10.00 (2.00:1) Beta: 1.95 Market Capitalization: $970.89 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.41 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $1.63 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/07/25

• Fundamental Ratios P/E Current FY Estimate: 9.42 Trailing 12 Months: 9.78 PEG Ratio: - Price Ratios Price/Book: 1.57 Price/Cash Flow: 8.42 Price / Sales: 2.47 EPS Growth vs. Year Ago Period: -36.59% vs. Previous Quarter: -31.58% Sales Growth vs. Year Ago Period: -3.00% vs. Previous Quarter: -20.42% ROE 06/30/25 - - 03/31/25 - 17.17 12/31/24 - 18.25 ROA 06/30/25 - - 03/31/25 - 15.20 12/31/24 - 16.33 Current Ratio 06/30/25 - - 03/31/25 - 8.73 12/31/24 - 10.23 Quick Ratio 06/30/25 - - 03/31/25 - 7.86 12/31/24 - 9.38 Operating Margin 06/30/25 - - 03/31/25 - 30.74 12/31/24 - 34.76 Net Margin 06/30/25 - - 03/31/25 - 44.79 12/31/24 - 45.91 Pre-Tax Margin 06/30/25 - - 03/31/25 - 35.64 12/31/24 - 36.34 Book Value 06/30/25 - - 03/31/25 - 8.91 12/31/24 - 10.12 Inventory Turnover 06/30/25 - - 03/31/25 - 1.34 12/31/24 - 1.40 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©